These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8927047)
1. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis. Bevan AP; Drake PG; Yale JF; Shaver A; Posner BI Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):49-58. PubMed ID: 8927047 [TBL] [Abstract][Full Text] [Related]
2. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen). Band CJ; Posner BI; Dumas V; Contreres JO Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395 [TBL] [Abstract][Full Text] [Related]
3. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. Posner BI; Faure R; Burgess JW; Bevan AP; Lachance D; Zhang-Sun G; Fantus IG; Ng JB; Hall DA; Lum BS J Biol Chem; 1994 Feb; 269(6):4596-604. PubMed ID: 8308031 [TBL] [Abstract][Full Text] [Related]
4. In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency. Bevan AP; Burgess JW; Yale JF; Drake PG; Lachance D; Baquiran G; Shaver A; Posner BI Am J Physiol; 1995 Jan; 268(1 Pt 1):E60-6. PubMed ID: 7840184 [TBL] [Abstract][Full Text] [Related]
5. Insulin receptor kinase-associated phosphotyrosine phosphatases in hepatic endosomes: assessing the role of phosphotyrosine phosphatase-1B. Li C; Baquiran G; Gu F; Tremblay ML; Fazel A; Bergeron JJ; Posner BI Endocrinology; 2006 Feb; 147(2):912-8. PubMed ID: 16269466 [TBL] [Abstract][Full Text] [Related]
6. A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo. Drake PG; Bevan AP; Burgess JW; Bergeron JJ; Posner BI Endocrinology; 1996 Nov; 137(11):4960-8. PubMed ID: 8895369 [TBL] [Abstract][Full Text] [Related]
7. Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action. Drake PG; Posner BI Mol Cell Biochem; 1998 May; 182(1-2):79-89. PubMed ID: 9609117 [TBL] [Abstract][Full Text] [Related]
8. A stable peroxovanadium compound with insulin-like action in human fat cells. Eriksson JW; Lönnroth P; Posner BI; Shaver A; Wesslau C; Smith UP Diabetologia; 1996 Feb; 39(2):235-42. PubMed ID: 8635677 [TBL] [Abstract][Full Text] [Related]
9. Insulin Signalling: The Inside Story. Posner BI Can J Diabetes; 2017 Feb; 41(1):108-113. PubMed ID: 27614806 [TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats. Yale JF; Lachance D; Bevan AP; Vigeant C; Shaver A; Posner BI Diabetes; 1995 Nov; 44(11):1274-9. PubMed ID: 7589823 [TBL] [Abstract][Full Text] [Related]
11. Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide. Matte C; Marquis JF; Blanchette J; Gros P; Faure R; Posner BI; Olivier M Eur J Immunol; 2000 Sep; 30(9):2555-64. PubMed ID: 11009089 [TBL] [Abstract][Full Text] [Related]
12. Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling. Bevan AP; Burgess JW; Drake PG; Shaver A; Bergeron JJ; Posner BI J Biol Chem; 1995 May; 270(18):10784-91. PubMed ID: 7537739 [TBL] [Abstract][Full Text] [Related]
13. Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line. Faure R; Vincent M; Dufour M; Shaver A; Posner BI J Cell Biochem; 1995 Nov; 59(3):389-401. PubMed ID: 8567756 [TBL] [Abstract][Full Text] [Related]
14. A peroxovanadium compound stimulates muscle glucose transport as powerfully as insulin and contractions combined. Nolte LA; Han DH; Hansen PA; Hucker KA; Holloszy JO Diabetes; 2003 Aug; 52(8):1918-25. PubMed ID: 12882906 [TBL] [Abstract][Full Text] [Related]
15. The chemistry of peroxovanadium compounds relevant to insulin mimesis. Shaver A; Ng JB; Hall DA; Posner BI Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):5-15. PubMed ID: 8927048 [TBL] [Abstract][Full Text] [Related]
16. Effects of bpV(pic) and bpV(phen) on H9c2 cardiomyoblasts during both hypoxia/reoxygenation and H2O2-induced injuries. Tian Y; Daoud A; Shang J Mol Med Rep; 2012 Mar; 5(3):852-8. PubMed ID: 22200881 [TBL] [Abstract][Full Text] [Related]
17. The insulinomimetic agents H2O2 and vanadate stimulate tyrosine phosphorylation of potential target proteins for the insulin receptor kinase in intact cells. Heffetz D; Rutter WJ; Zick Y Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):631-5. PubMed ID: 1281409 [TBL] [Abstract][Full Text] [Related]
18. Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects. Fantus IG; Tsiani E Mol Cell Biochem; 1998 May; 182(1-2):109-19. PubMed ID: 9609120 [TBL] [Abstract][Full Text] [Related]
19. Role of protein tyrosine phosphatases in the regulation of interferon-{gamma}-induced macrophage nitric oxide generation: implication of ERK pathway and AP-1 activation. Blanchette J; Pouliot P; Olivier M J Leukoc Biol; 2007 Mar; 81(3):835-44. PubMed ID: 17170076 [TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia potentiates H(2)O(2) production in adipocytes and enhances insulin signal transduction: potential role for oxidative inhibition of thiol-sensitive protein-tyrosine phosphatases. Wu X; Zhu L; Zilbering A; Mahadev K; Motoshima H; Yao J; Goldstein BJ Antioxid Redox Signal; 2005; 7(5-6):526-37. PubMed ID: 15889998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]